Exabis Library
Welcome to the e-CCO Library!
P486: Response to vedolizumab therapy in patients with inflammatory bowel disease: Impact of drug levels, anti-drug antibodies and α4β7 target occupancy
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P486: Treatment-emergent COVID-19 infections in ozanimod ulcerative colitis and multiple sclerosis clinical trials
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P487 Development and validation of a new patient-reported outcome measure for Crohn’s perianal fistula: Crohn’s anal fistula quality-of-life (CAF-QoL) scale
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P487: Anti TNF induced psoariasiform skin eruptions are increasing in in the biosimilar era – a descriptive study of drug induced skin manifestations and their management
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P487: Early vedolizumab trough levels are not associated with a short-term response in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P487: Effectiveness and safety of CT-P13 under routine care in paediatric patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P487: Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes (SCAR Study)
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P487: The effect of a coordinated care programme for inflammatory bowel diseases on health care utilisation
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P487: The feasibility of a digital platform for improving disease management among patients with Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P487: Tofacitinib for the treatment of ulcerative colitis: Analysis of infection rates from the OCTAVE clinical programme
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P488 How reliable is the online medical information on paediatric inflammatory bowel diseases?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P488: Does Statin use reduce the risk of J-pouch related complications in patients with inflammatory bowel disease?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P488: Efficacy of pre-operative oral antibiotic prophylaxis for the prevention of wound infections in patients with Crohn's disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P488: IBS-type symptoms in patients with quiescent inflammatory bowel disease are unrelated to ongoing inflammation
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P488: Perianal Crohn's disease in the biological era
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P488: Switch from intravenous to subcutaneous infliximab in patients with Inflammatory Bowel Disease: efficacy, safety and patients' acceptance
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P488: The COVID19 pandemic impact on Inflammatory Bowel Disease Patients Management in a Romanian Tertiary Gastroenterology Centre
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P488: Trends in corticosteroid (CS) use over time and following diagnosis in patients with Inflammatory Bowel Disease (IBD), using IBM® MarketScan®
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P489 Are patients with inflammatory bowel disease receiving an adequate immunisation?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P489: Clinical experience with ustekinumab in selected Crohn's disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM